SCHEMBL10897828

SCHEMBL10897828

Clc1ccc(CN2CCCNCC2)cc1Cl

nearest known ligand 0.76

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
CXCR4 P61073 11/20 0.76
MEN1 O00255 1/20 0.76
CHRM2 P08172 1/20 0.76
CHRM1 P11229 1/20 0.76
ADRA2C P18825 1/20 0.76
CCR2 P41597 1/20 0.76
CXCL12 P48061 1/20 0.76
BLM P54132 1/20 0.76
KMT2A Q03164 1/20 0.76
TDP1 Q9NUW8 1/20 0.76
HRH3 Q9Y5N1 1/20 0.76
SIGMAR1 Q99720 4/20 0.74
POLB P06746 1/20 0.71
SMN1; SMN2 Q16637 1/20 0.71

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30239538 0.94 SIGMAR1 (0.71) CXCR4MEN1CHRM2CHRM1ADRA2C
SCHEMBL593869 0.94 SIGMAR1 (0.71) CXCR4MEN1CHRM2CHRM1ADRA2C
Hydrochloric Acid SCHEMBL6645506 0.92 SIGMAR1 (0.69) CXCR4MEN1CHRM2CHRM1ADRA2C
Piperazine SCHEMBL28078028 0.92 SIGMAR1 (0.69) CXCR4MEN1CHRM2CHRM1ADRA2C
Plerixafor SCHEMBL19038 0.87 CXCR4 (1.00) CXCR4MEN1CHRM2CHRM1ADRA2C
SCHEMBL5611617 0.87 CXCR4 (1.00) CXCR4MEN1CHRM2CHRM1ADRA2C
SCHEMBL29490414 0.87 CXCR4 (1.00) CXCR4MEN1CHRM2CHRM1ADRA2C
Hydrochloric Acid SCHEMBL7612104 0.85 CXCR4 (1.00) CXCR4MEN1CHRM2CHRM1ADRA2C
Hydrochloric Acid SCHEMBL7610931 0.85 CXCR4 (1.00) CXCR4MEN1CHRM2CHRM1ADRA2C
Plerixafor SCHEMBL414153 0.85 CXCR4 (1.00) CXCR4MEN1CHRM2CHRM1ADRA2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4599414-A ANTHISTAMINES, VASODILATORS EISAI CO., LTD. (JP) 1986-07-08 US disclosed
EP-0023350-A1 Theophylline derivatives, a process for the preparation of the same and a therapeutical composition Eisai Co., Ltd. (JP) 1981-02-04 EP disclosed